Cargando…
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
INTRODUCTION: It has become increasingly important to include patient preference information in decision-making processes for drug development. As neuromuscular disorders represent multisystem, debilitating, and progressive rare diseases with few treatment options, this study aimed to explore unmet...
Autores principales: | Jimenez-Moreno, A. Cecilia, van Overbeeke, Eline, Pinto, Cathy Anne, Smith, Ian, Sharpe, Jenny, Ormrod, James, Whichello, Chiara, de Bekker-Grob, Esther W., Bullok, Kristin, Levitan, Bennett, Huys, Isabelle, de Wit, G. Ardine, Gorman, Grainne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357717/ https://www.ncbi.nlm.nih.gov/pubmed/33660162 http://dx.doi.org/10.1007/s40271-020-00482-z |
Ejemplares similares
-
Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
por: Jimenez-Moreno, A. Cecilia, et al.
Publicado: (2021) -
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
por: Jimenez-Moreno, Aura Cecilia, et al.
Publicado: (2020) -
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
por: van Overbeeke, Eline, et al.
Publicado: (2019) -
Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
por: Janssens, Rosanne, et al.
Publicado: (2019) -
Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison
por: Whichello, Chiara, et al.
Publicado: (2020)